These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 25841320

  • 1. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H, Li C.
    Neuroscience; 2015 Jul 09; 298():12-25. PubMed ID: 25841320
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL.
    Aging Cell; 2006 Apr 09; 5(2):153-65. PubMed ID: 16626394
    [Abstract] [Full Text] [Related]

  • 3. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons.
    Castillo K, Nassif M, Valenzuela V, Rojas F, Matus S, Mercado G, Court FA, van Zundert B, Hetz C.
    Autophagy; 2013 Sep 09; 9(9):1308-20. PubMed ID: 23851366
    [Abstract] [Full Text] [Related]

  • 4. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S, Fabbrizio P, Amadio S, Volonté C.
    J Neuroinflammation; 2016 Aug 22; 13(1):191. PubMed ID: 27549088
    [Abstract] [Full Text] [Related]

  • 5. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J, Kim TY, Cho KS, Kim HN, Koh JY.
    Neurobiol Dis; 2013 Nov 22; 59():80-5. PubMed ID: 23891729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
    Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W.
    Autophagy; 2014 Apr 22; 10(4):588-602. PubMed ID: 24441414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK, Weston RH, Perera ND, D'Amico A, Nutt SL, Turner BJ.
    J Neuroinflammation; 2015 Feb 27; 12():40. PubMed ID: 25889790
    [Abstract] [Full Text] [Related]

  • 10. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE, Rasmussen AL, Bennett W, King A, West AK, Chung RS, Chuah MI.
    J Neuroinflammation; 2014 Mar 23; 11():55. PubMed ID: 24655927
    [Abstract] [Full Text] [Related]

  • 11. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A, Sironi F, Tortarolo M, Gatto N, De Gioia R, Pasetto L, De Paola M, Mariani A, Ghosh S, Watson R, Kalmes A, Bonetto V, Bendotti C.
    J Neuroinflammation; 2018 Mar 01; 15(1):65. PubMed ID: 29495962
    [Abstract] [Full Text] [Related]

  • 12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 01; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 13. Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.
    Pozzi S, Thammisetty SS, Julien JP.
    Neurotherapeutics; 2018 Jul 01; 15(3):715-727. PubMed ID: 29790082
    [Abstract] [Full Text] [Related]

  • 14. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G, Iennaco R, Fusi N, Heath PR, Marino M, Trolese MC, Ferraiuolo L, Lawrence N, Shaw PJ, Bendotti C.
    Brain; 2013 Nov 01; 136(Pt 11):3305-32. PubMed ID: 24065725
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of Withania somnifera extract in SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Dutta K, Patel P, Julien JP.
    Exp Neurol; 2018 Nov 01; 309():193-204. PubMed ID: 30134145
    [Abstract] [Full Text] [Related]

  • 16. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
    Zhang JJ, Zhou QM, Chen S, Le WD.
    CNS Neurosci Ther; 2018 Dec 01; 24(12):1163-1174. PubMed ID: 29656576
    [Abstract] [Full Text] [Related]

  • 17. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y, Sakumi K, Kajitani K, Kadoya T, Horie H, Kira J, Nakabeppu Y.
    Neuropathol Appl Neurobiol; 2015 Feb 01; 41(2):227-44. PubMed ID: 24707896
    [Abstract] [Full Text] [Related]

  • 18. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV, Gu H, Liu Q, Zhu TZ, Zhou C, Johnstone BH, March KL, Pascuzzi RM, Farlow MR, Du Y.
    Sci Rep; 2015 Nov 20; 5():16953. PubMed ID: 26586020
    [Abstract] [Full Text] [Related]

  • 19. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
    Shimojo Y, Kosaka K, Noda Y, Shimizu T, Shirasawa T.
    J Neurosci Res; 2010 Mar 20; 88(4):896-904. PubMed ID: 19798750
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.